{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:44:40Z","timestamp":1793083480667,"version":"4.5.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Institute for Health","award":["1K08HL145108-01A1"],"award-info":[{"award-number":["1K08HL145108-01A1"]}]},{"name":"National Institute for Health","award":["1K08HL145108-01A1"],"award-info":[{"award-number":["1K08HL145108-01A1"]}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"crossref","award":["1R01HL160716-01"],"award-info":[{"award-number":["1R01HL160716-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11886-022-01722-4","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T09:05:08Z","timestamp":1654938308000},"page":"935-946","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["The Role of B Cells in Cardiomyopathy and Heart Failure"],"prefix":"10.1007","volume":"24","author":[{"given":"Kevin","family":"Bermea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aashik","family":"Bhalodia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Huff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2704-978X","authenticated-orcid":false,"given":"Luigi","family":"Adamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"key":"1722_CR1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-animal-031412-103651","volume":"1","author":"D Parra","year":"2013","unstructured":"Parra D, Takizawa F, Sunyer JO. Evolution of B cell immunity. Annu Rev Anim Biosci. 2013;1:65\u201397.","journal-title":"Annu Rev Anim Biosci"},{"issue":"5","key":"1722_CR2","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","volume":"112","author":"TW LeBien","year":"2008","unstructured":"LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood. 2008;112(5):1570\u201380.","journal-title":"Blood"},{"issue":"2","key":"1722_CR3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00005-008-0014-5","volume":"56","author":"X Chen","year":"2008","unstructured":"Chen X, Jensen PE. The role of B lymphocytes as antigen-presenting cells. Arch Immunol Ther Exp (Warsz). 2008;56(2):77\u201383.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"1722_CR4","doi-asserted-by":"crossref","unstructured":"Fillatreau S.\u00a0Cytokine-producing B cells as regulators of pathogenic and protective immune responses. Ann Rheum Dis.\u00a02013;72(suppl 2):ii80.","DOI":"10.1136\/annrheumdis-2012-202253"},{"key":"1722_CR5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev.iy.11.040193.002441","volume":"11","author":"AB Kantor","year":"1993","unstructured":"Kantor AB, Herzenberg LA. Origin of murine B cell lineages. Annu Rev Immunol. 1993;11:501\u201338.","journal-title":"Annu Rev Immunol"},{"key":"1722_CR6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-3-0348-0706-7_2","volume-title":"Drugs targeting B-cells in autoimmune diseases","author":"MS Naradikian","year":"2014","unstructured":"Naradikian MS, et al. Understanding B cell biology. In: Bosch X, Ramos-Casals M, Khamashta MA, editors., et al., Drugs targeting B-cells in autoimmune diseases. Basel: Springer Basel; 2014. p. 11\u201335."},{"issue":"10","key":"1722_CR7","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.4049\/jimmunol.171.10.5406","volume":"171","author":"T Kawahara","year":"2003","unstructured":"Kawahara T, et al. Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells. J Immunol. 2003;171(10):5406\u201314.","journal-title":"J Immunol"},{"key":"1722_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-1161-5_2","volume":"1190","author":"V Yenson","year":"2014","unstructured":"Yenson V, Baumgarth N. Purification and immune phenotyping of B-1 cells from body cavities of mice. Methods Mol Biol. 2014;1190:17\u201334.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"1722_CR9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2011.11.017","volume":"36","author":"E Montecino-Rodriguez","year":"2012","unstructured":"Montecino-Rodriguez E, Dorshkind K. B-1 B cell development in the fetus and adult. Immunity. 2012;36(1):13\u201321.","journal-title":"Immunity"},{"key":"1722_CR10","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Adamo L, et al.\u00a0Modulation of subsets of cardiac B lymphocytes improves cardiac function after acute injury. JCI Insight.\u00a02018;3(11). Findings from this study demonstrate for the first time that small molecule\u2013mediate modulation of B cells improves cardiac function after acute ischemic injury and therefore point at B cells as a viable therapeutic target for the prevention of heart failure after myocardial infarction.","DOI":"10.1172\/jci.insight.120137"},{"issue":"2","key":"1722_CR11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri3383","volume":"13","author":"A Cerutti","year":"2013","unstructured":"Cerutti A, Cols M, Puga I. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol. 2013;13(2):118\u201332.","journal-title":"Nat Rev Immunol"},{"issue":"6585","key":"1722_CR12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/381751a0","volume":"381","author":"K Rajewsky","year":"1996","unstructured":"Rajewsky K. Clonal selection and learning in the antibody system. Nature. 1996;381(6585):751\u20138.","journal-title":"Nature"},{"issue":"12","key":"1722_CR13","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/eji.1830191223","volume":"19","author":"NA Bos","year":"1989","unstructured":"Bos NA, et al. Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in germ-free BALB\/c mice fed chemically defined ultrafiltered diet. Eur J Immunol. 1989;19(12):2335\u20139.","journal-title":"Eur J Immunol"},{"issue":"4","key":"1722_CR14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.5114\/ceji.2018.81354","volume":"43","author":"J Palma","year":"2018","unstructured":"Palma J, et al. Natural antibodies - facts known and unknown. Cent Eur J Immunol. 2018;43(4):466\u201375.","journal-title":"Cent Eur J Immunol"},{"issue":"12","key":"1722_CR15","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.it.2016.10.003","volume":"37","author":"BA Heesters","year":"2016","unstructured":"Heesters BA, et al. Antigen presentation to B cells. Trends Immunol. 2016;37(12):844\u201354.","journal-title":"Trends Immunol"},{"issue":"2","key":"1722_CR16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0952-7915(02)00327-8","volume":"14","author":"M Diaz","year":"2002","unstructured":"Diaz M, Casali P. Somatic immunoglobulin hypermutation. Curr Opin Immunol. 2002;14(2):235\u201340.","journal-title":"Curr Opin Immunol"},{"key":"1722_CR17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.iy.10.040192.000525","volume":"10","author":"M Reth","year":"1992","unstructured":"Reth M. Antigen receptors on B lymphocytes. Annu Rev Immunol. 1992;10:97\u2013121.","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"1722_CR18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri3802","volume":"15","author":"T Kurosaki","year":"2015","unstructured":"Kurosaki T, Kometani K, Ise W. Memory B cells. Nat Rev Immunol. 2015;15(3):149\u201359.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"1722_CR19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nri3818","volume":"15","author":"PA Roche","year":"2015","unstructured":"Roche PA, Furuta K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat Rev Immunol. 2015;15(4):203\u201316.","journal-title":"Nat Rev Immunol"},{"issue":"20","key":"1722_CR20","doi-asserted-by":"crossref","first-page":"16636","DOI":"10.1074\/jbc.M112.357640","volume":"287","author":"B Katkere","year":"2012","unstructured":"Katkere B, Rosa S, Drake JR. The Syk-binding ubiquitin ligase c-Cbl mediates signaling-dependent B cell receptor ubiquitination and B cell receptor-mediated antigen processing and presentation. J Biol Chem. 2012;287(20):16636\u201344.","journal-title":"J Biol Chem"},{"key":"1722_CR21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3389\/fimmu.2017.00319","volume":"8","author":"LN Adler","year":"2017","unstructured":"Adler LN, et al. The other function: class II-restricted antigen presentation by B cells. Front Immunol. 2017;8:319\u2013319.","journal-title":"Front Immunol"},{"issue":"6","key":"1722_CR22","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.4049\/jimmunol.172.6.3422","volume":"172","author":"ME Duddy","year":"2004","unstructured":"Duddy ME, Alter A, Bar-Or A. Distinct profiles of human B cell effector cytokines: a role in immune regulation? J Immunol. 2004;172(6):3422\u20137.","journal-title":"J Immunol"},{"issue":"7","key":"1722_CR23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nri3857","volume":"15","author":"P Shen","year":"2015","unstructured":"Shen P, Fillatreau S. Antibody-independent functions of B cells: a focus on cytokines. Nat Rev Immunol. 2015;15(7):441\u201351.","journal-title":"Nat Rev Immunol"},{"key":"1722_CR24","unstructured":"\u2022\u2022 Zouggari Y, et al. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med. 2013;19(10):1273\u201380. Findings from this study demonstrate for the first time a functional connection between B lymphocytes and the heart."},{"issue":"10","key":"1722_CR25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/intimm\/dxv028","volume":"27","author":"BG Chousterman","year":"2015","unstructured":"Chousterman BG, Swirski FK. Innate response activator B cells: origins and functions. Int Immunol. 2015;27(10):537\u201341.","journal-title":"Int Immunol"},{"issue":"4","key":"1722_CR26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","volume":"42","author":"EC Rosser","year":"2015","unstructured":"Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function. Immunity. 2015;42(4):607\u201312.","journal-title":"Immunity"},{"issue":"5","key":"1722_CR27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nm.3842","volume":"21","author":"M Chimen","year":"2015","unstructured":"Chimen M, et al. Homeostatic regulation of T cell trafficking by a B cell-derived peptide is impaired in autoimmune and chronic inflammatory disease. Nat Med. 2015;21(5):467\u201375.","journal-title":"Nat Med"},{"issue":"10","key":"1722_CR28","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1111\/j.1600-6143.2012.04180.x","volume":"12","author":"CN Magee","year":"2012","unstructured":"Magee CN, Boenisch O, Najafian N. The role of costimulatory molecules in directing the functional differentiation of alloreactive T helper cells. Am J Transplant. 2012;12(10):2588\u2013600.","journal-title":"Am J Transplant"},{"key":"1722_CR29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1098\/rspb.1964.0001","volume":"159","author":"JL Gowans","year":"1964","unstructured":"Gowans JL, Knight EJ. The route of re-circulation of lymphocytes in the rat. Proc R Soc Lond B Biol Sci. 1964;159:257\u201382.","journal-title":"Proc R Soc Lond B Biol Sci"},{"issue":"1","key":"1722_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1074-7613(01)00261-8","volume":"16","author":"EJ Kunkel","year":"2002","unstructured":"Kunkel EJ, Butcher EC. Chemokines and the tissue-specific migration of lymphocytes. Immunity. 2002;16(1):1\u20134.","journal-title":"Immunity"},{"issue":"2","key":"1722_CR31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000078497","volume":"134","author":"T Tanaka","year":"2004","unstructured":"Tanaka T, et al. Molecular determinants controlling homeostatic recirculation and tissue-specific trafficking of lymphocytes. Int Arch Allergy Immunol. 2004;134(2):120\u201334.","journal-title":"Int Arch Allergy Immunol"},{"key":"1722_CR32","doi-asserted-by":"crossref","unstructured":"Adamo L, et al.\u00a0Modulation of subsets of cardiac B lymphocytes improves cardiac function after acute injury. JCI Insight. 2018;3(11).","DOI":"10.1172\/jci.insight.120137"},{"key":"1722_CR33","doi-asserted-by":"crossref","unstructured":"Bonner F, et al.\u00a0Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury. PLoS One. 7(4):e34730.","DOI":"10.1371\/journal.pone.0034730"},{"key":"1722_CR34","doi-asserted-by":"crossref","unstructured":"Rocha-Resende C, et al.\u00a0Developmental changes in myocardial B cells mirror changes in B cells associated with different organs. JCI Insight, 2020;5(16).","DOI":"10.1172\/jci.insight.139377"},{"key":"1722_CR35","doi-asserted-by":"crossref","unstructured":"Horckmans M, et al.\u00a0Pericardial adipose tissue regulates granulopoiesis, fibrosis and cardiac function after myocardial infarction. Circulation.\u00a02017.","DOI":"10.1161\/CIRCULATIONAHA.117.028833"},{"issue":"43","key":"1722_CR36","doi-asserted-by":"crossref","first-page":"21673","DOI":"10.1073\/pnas.1911464116","volume":"116","author":"L Wu","year":"2019","unstructured":"Wu L, et al. IL-10-producing B cells are enriched in murine pericardial adipose tissues and ameliorate the outcome of acute myocardial infarction. Proc Natl Acad Sci U S A. 2019;116(43):21673\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1722_CR37","doi-asserted-by":"crossref","unstructured":"Adamo L, et al.\u00a0Myocardial B cells are a subset of circulating lymphocytes with delayed transit through the heart. JCI Insight.\u00a02020;5(3).","DOI":"10.1172\/jci.insight.134700"},{"key":"1722_CR38","doi-asserted-by":"crossref","unstructured":"\u2022 Rocha-Resende C, Pani F, Adamo L. B cells modulate the expression of MHC-II on cardiac CCR2(-) macrophages. J Mol Cell Cardiol. 2021;157:98\u2013103. A large body of literature indicates that cardiac macrophages play an important role in heart failure. Findings from this study show that B cells modulate the phenotype of cardiac macrophage and therefore strengthen the emerging paradigm of a tight connection between B cells and heart failure.","DOI":"10.1016\/j.yjmcc.2021.05.003"},{"key":"1722_CR39","unstructured":"Noutsias M, et al. Phenotypic characterization of infiltrates in dilated cardiomyopathy - diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy. Med Sci Monit.\u00a02002;8(7):CR478\u201387."},{"issue":"7838","key":"1722_CR40","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","volume":"588","author":"M Litvinukova","year":"2020","unstructured":"Litvinukova M, et al. Cells of the adult human heart. Nature. 2020;588(7838):466\u201372.","journal-title":"Nature"},{"key":"1722_CR41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yjmcc.2013.04.023","volume":"62","author":"X Yan","year":"2013","unstructured":"Yan X, et al. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J Mol Cell Cardiol. 2013;62:24\u201335.","journal-title":"J Mol Cell Cardiol"},{"issue":"13","key":"1722_CR42","first-page":"2664","volume":"117","author":"M Heinrichs","year":"2021","unstructured":"Heinrichs M, et al. The healing myocardium mobilizes a distinct B-cell subset through a CXCL13-CXCR5-dependent mechanism. Cardiovasc Res. 2021;117(13):2664\u201376.","journal-title":"Cardiovasc Res"},{"key":"1722_CR43","doi-asserted-by":"crossref","unstructured":"Wu L,\u00a0et al. P2y12 Receptor promotes pressure overload-induced cardiac remodeling via platelet-driven inflammation in mice. Hypertension. 70(4):759\u2013769.","DOI":"10.1161\/HYPERTENSIONAHA.117.09262"},{"issue":"1","key":"1722_CR44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.21037\/cdt-20-302","volume":"11","author":"RHG Schwinger","year":"2021","unstructured":"Schwinger RHG. Pathophysiology of heart failure. Cardiovascular diagnosis and therapy. 2021;11(1):263\u201376.","journal-title":"Cardiovascular diagnosis and therapy"},{"issue":"5","key":"1722_CR45","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","volume":"17","author":"L Adamo","year":"2020","unstructured":"Adamo L, et al. Reappraising the role of inflammation in heart failure. Nat Rev Cardiol. 2020;17(5):269\u201385.","journal-title":"Nat Rev Cardiol"},{"issue":"17","key":"1722_CR46","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2020.08.061","volume":"76","author":"L Adamo","year":"2020","unstructured":"Adamo L, et al. Proteomic signatures of heart failure in relation to left ventricular ejection fraction. J Am Coll Cardiol. 2020;76(17):1982\u201394.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1722_CR47","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/0735-1097(93)90546-D","volume":"22","author":"N Latif","year":"1993","unstructured":"Latif N, et al. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. J Am Coll Cardiol. 1993;22(5):1378\u201384.","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"1722_CR48","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/eurheartj\/eht506","volume":"35","author":"KA Youker","year":"2014","unstructured":"Youker KA, et al. High proportion of patients with end-stage heart failure regardless of aetiology demonstrates anti-cardiac antibody deposition in failing myocardium: humoral activation, a potential contributor of disease progression. Eur Heart J. 2014;35(16):1061\u20138.","journal-title":"Eur Heart J"},{"issue":"5","key":"1722_CR49","doi-asserted-by":"crossref","first-page":"H1358","DOI":"10.1152\/ajpheart.00144.2018","volume":"315","author":"L Keppner","year":"2018","unstructured":"Keppner L, et al. Antibodies aggravate the development of ischemic heart failure. Am J Physiol Heart Circ Physiol. 2018;315(5):H1358-h1367.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"1722_CR50","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/01.CIR.81.3.959","volume":"81","author":"K Schulze","year":"1990","unstructured":"Schulze K, et al. Antibodies to ADP-ATP carrier\u2013an autoantigen in myocarditis and dilated cardiomyopathy\u2013impair cardiac function. Circulation. 1990;81(3):959\u201369.","journal-title":"Circulation"},{"issue":"3","key":"1722_CR51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1242\/dmm.027409","volume":"10","author":"MG Hasham","year":"2017","unstructured":"Hasham MG, et al. Systemic autoimmunity induced by the TLR7\/8 agonist Resiquimod causes myocarditis and dilated cardiomyopathy in a new mouse model of autoimmune heart disease. Dis Model Mech. 2017;10(3):259\u201370.","journal-title":"Dis Model Mech"},{"issue":"12","key":"1722_CR52","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/nm955","volume":"9","author":"T Okazaki","year":"2003","unstructured":"Okazaki T, et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med. 2003;9(12):1477\u201383.","journal-title":"Nat Med"},{"issue":"23","key":"1722_CR53","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1161\/CIRCULATIONAHA.119.043171","volume":"141","author":"M Bockstahler","year":"2020","unstructured":"Bockstahler M, et al. Heart-specific immune responses in an animal model of autoimmune-related myocarditis mitigated by an immunoproteasome inhibitor and genetic ablation. Circulation. 2020;141(23):1885\u2013902.","journal-title":"Circulation"},{"issue":"2","key":"1722_CR54","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1006\/jmcc.1996.0307","volume":"29","author":"S Matsui","year":"1997","unstructured":"Matsui S, et al. Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol. 1997;29(2):641\u201355.","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"1722_CR55","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ahj.2010.01.012","volume":"159","author":"LR Herda","year":"2010","unstructured":"Herda LR, et al. Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy. Am Heart J. 2010;159(5):809\u201316.","journal-title":"Am Heart J"},{"issue":"4","key":"1722_CR56","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ahj.2004.11.002","volume":"150","author":"A Staudt","year":"2005","unstructured":"Staudt A, et al. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption. Am Heart J. 2005;150(4):729\u201336.","journal-title":"Am Heart J"},{"issue":"19","key":"1722_CR57","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1161\/01.CIR.0000036746.49449.64","volume":"106","author":"A Staudt","year":"2002","unstructured":"Staudt A, et al. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation. 2002;106(19):2448\u201353.","journal-title":"Circulation"},{"issue":"1","key":"1722_CR58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.RES.64.1.97","volume":"64","author":"CJ Limas","year":"1989","unstructured":"Limas CJ, Goldenberg IF, Limas C. Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res. 1989;64(1):97\u2013103.","journal-title":"Circ Res"},{"issue":"5","key":"1722_CR59","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/01.CIR.99.5.649","volume":"99","author":"R Jahns","year":"1999","unstructured":"Jahns R, et al. Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation. 1999;99(5):649\u201354.","journal-title":"Circulation"},{"issue":"13","key":"1722_CR60","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.CIR.103.13.1765","volume":"103","author":"PA Chiale","year":"2001","unstructured":"Chiale PA, et al. Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation. 2001;103(13):1765\u201371.","journal-title":"Circulation"},{"issue":"4","key":"1722_CR61","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ahj.2006.05.004","volume":"152","author":"S St\u00f6rk","year":"2006","unstructured":"St\u00f6rk S, et al. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Am Heart J. 2006;152(4):697\u2013704.","journal-title":"Am Heart J"},{"issue":"11","key":"1722_CR62","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0735-1097(02)01865-X","volume":"39","author":"HR Liu","year":"2002","unstructured":"Liu HR, et al. Relationship of myocardial remodeling to the genesis of serum autoantibodies to cardiac beta(1)-adrenoceptors and muscarinic type 2 acetylcholine receptors in rats. J Am Coll Cardiol. 2002;39(11):1866\u201373.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1722_CR63","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1006\/jmcc.2001.1414","volume":"33","author":"T Christ","year":"2001","unstructured":"Christ T, et al. Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. J Mol Cell Cardiol. 2001;33(8):1515\u201325.","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"1722_CR64","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/01.RES.88.6.578","volume":"88","author":"M Iwata","year":"2001","unstructured":"Iwata M, et al. Autoimmunity against the second extracellular loop of beta(1)-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo. Circ Res. 2001;88(6):578\u201386.","journal-title":"Circ Res"},{"key":"1722_CR65","doi-asserted-by":"crossref","unstructured":"Jane-wit D, Altuntas CZ, Johnson JM, Yong S, Wickley PJ, Clark P, Wang Q, Popovic ZB, Penn MS, Damron DS, Perez DM. \u03b21-Adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis. Circulation. 2007;116(4):399-410.","DOI":"10.1161\/CIRCULATIONAHA.106.683193"},{"issue":"3","key":"1722_CR66","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cardfail.2008.10.027","volume":"15","author":"Y Nagatomo","year":"2009","unstructured":"Nagatomo Y, et al. A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure. J Card Fail. 2009;15(3):224\u201332.","journal-title":"J Card Fail"},{"issue":"5","key":"1722_CR67","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1172\/JCI116416","volume":"91","author":"LX Fu","year":"1993","unstructured":"Fu LX, et al. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest. 1993;91(5):1964\u20138.","journal-title":"J Clin Invest"},{"issue":"3","key":"1722_CR68","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijcard.2009.11.025","volume":"148","author":"S Stavrakis","year":"2011","unstructured":"Stavrakis S, et al. Opposing cardiac effects of autoantibody activation of \u03b2-adrenergic and M2 muscarinic receptors in cardiac-related diseases. Int J Cardiol. 2011;148(3):331\u20136.","journal-title":"Int J Cardiol"},{"issue":"16","key":"1722_CR69","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/eurheartj\/ehn268","volume":"29","author":"F Leuschner","year":"2008","unstructured":"Leuschner F, et al. Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction. Eur Heart J. 2008;29(16):1949\u201355.","journal-title":"Eur Heart J"},{"issue":"6","key":"1722_CR70","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00395-015-0517-2","volume":"110","author":"A Haghikia","year":"2015","unstructured":"Haghikia A, et al. Evidence of autoantibodies against cardiac troponin I and sarcomeric myosin in peripartum cardiomyopathy. Basic Res Cardiol. 2015;110(6):60.","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"1722_CR71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0090-1229(87)90164-4","volume":"43","author":"FL Alvarez","year":"1987","unstructured":"Alvarez FL, et al. Heart-specific autoantibodies induced by Coxsackievirus B3: identification of heart autoantigens. Clin Immunol Immunopathol. 1987;43(1):129\u201339.","journal-title":"Clin Immunol Immunopathol"},{"key":"1722_CR72","doi-asserted-by":"crossref","unstructured":"Zhang Y, et al. Low level antibodies against alpha-tropomyosin are associated with increased risk of coronary heart disease. Front Pharmacol. 2020;11.","DOI":"10.3389\/fphar.2020.00195"},{"issue":"2","key":"1722_CR73","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2006.04.077","volume":"117","author":"H Shmilovich","year":"2007","unstructured":"Shmilovich H, et al. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy. Int J Cardiol. 2007;117(2):198\u2013203.","journal-title":"Int J Cardiol"},{"issue":"1","key":"1722_CR74","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ahj.2008.02.015","volume":"156","author":"M Landsberger","year":"2008","unstructured":"Landsberger M, et al. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy. Am Heart J. 2008;156(1):92-99.e2.","journal-title":"Am Heart J"},{"issue":"6","key":"1722_CR75","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0735-1097(02)02075-2","volume":"40","author":"A Baba","year":"2002","unstructured":"Baba A, Yoshikawa T, Ogawa S. Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2002;40(6):1153\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1722_CR76","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.yjmcc.2006.02.006","volume":"41","author":"M Zhang","year":"2006","unstructured":"Zhang M, et al. The role of natural IgM in myocardial ischemia-reperfusion injury. J Mol Cell Cardiol. 2006;41(1):62\u20137.","journal-title":"J Mol Cell Cardiol"},{"issue":"11","key":"1722_CR77","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1073\/pnas.0400347101","volume":"101","author":"M Zhang","year":"2004","unstructured":"Zhang M, et al. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia\/reperfusion injury. Proc Natl Acad Sci U S A. 2004;101(11):3886\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1722_CR78","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.606407","volume":"8","author":"CW Vogel","year":"2020","unstructured":"Vogel CW. The role of complement in myocardial infarction reperfusion injury: an underappreciated therapeutic target. Front Cell Dev Biol. 2020;8:606407.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"1722_CR79","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.297.1.43","volume":"297","author":"AA Investigators","year":"2007","unstructured":"Investigators AA, et al. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA. 2007;297(1):43\u201351.","journal-title":"JAMA"},{"key":"1722_CR80","doi-asserted-by":"crossref","unstructured":"Martel C, et al. Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Am Heart J.\u00a02012;164(1):43\u201351.","DOI":"10.1016\/j.ahj.2012.04.007"},{"key":"1722_CR81","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fimmu.2017.00603","volume":"8","author":"RJ Ludwig","year":"2017","unstructured":"Ludwig RJ, et al. Mechanisms of autoantibody-induced pathology. Front Immunol. 2017;8:603.","journal-title":"Front Immunol"},{"issue":"29","key":"1722_CR82","doi-asserted-by":"crossref","first-page":"10179","DOI":"10.1073\/pnas.0804910105","volume":"105","author":"SB Haudek","year":"2008","unstructured":"Haudek SB, et al. Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells. Proc Natl Acad Sci U S A. 2008;105(29):10179\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"1722_CR83","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.jacc.2006.11.051","volume":"49","author":"A Staudt","year":"2007","unstructured":"Staudt A, et al. Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy. J Am Coll Cardiol. 2007;49(16):1684\u201392.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1722_CR84","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1054\/jcaf.2001.27829","volume":"7","author":"A Doing","year":"2001","unstructured":"Doing A, et al. B-cell function in chronic heart failure: antibody response to pneumococcal vaccine. J Card Fail. 2001;7(4):318\u201321.","journal-title":"J Card Fail"},{"issue":"7","key":"1722_CR85","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacc.2021.11.051","volume":"79","author":"Y Sun","year":"2022","unstructured":"Sun Y, et al. Splenic marginal zone B lymphocytes regulate cardiac remodeling after acute myocardial infarction in mice. J Am Coll Cardiol. 2022;79(7):632\u201347.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1722_CR86","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12872-020-01775-9","volume":"21","author":"F Mo","year":"2021","unstructured":"Mo F, et al. Are activated B cells involved in the process of myocardial fibrosis after acute myocardial infarction? An in vivo experiment. BMC Cardiovasc Disord. 2021;21(1):5.","journal-title":"BMC Cardiovasc Disord"},{"key":"1722_CR87","doi-asserted-by":"crossref","unstructured":"Hanna A, Frangogiannis NG. The role of the TGF-\u03b2 superfamily in myocardial infarction. Front Cardiovasc Med.\u00a02019;6.","DOI":"10.3389\/fcvm.2019.00140"},{"issue":"3","key":"1722_CR88","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s10753-018-0950-0","volume":"42","author":"Y Li","year":"2019","unstructured":"Li Y, et al. B cells increase myocardial inflammation by suppressing M2 macrophage polarization in Coxsackie virus B3-induced acute myocarditis. Inflammation. 2019;42(3):953\u201360.","journal-title":"Inflammation"},{"issue":"4","key":"1722_CR89","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0002-9440(10)65223-6","volume":"155","author":"I Mena","year":"1999","unstructured":"Mena I, et al. The role of B lymphocytes in coxsackievirus B3 infection. Am J Pathol. 1999;155(4):1205\u201315.","journal-title":"Am J Pathol"},{"key":"1722_CR90","doi-asserted-by":"crossref","unstructured":"Lu J, et al. The absence of B cells disrupts splenic and myocardial Treg homeostasis in coxsackievirus B3-induced myocarditis. Clin Exp Immunol.\u00a02022.","DOI":"10.1093\/cei\/uxac015"},{"issue":"5","key":"1722_CR91","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s10875-013-9889-y","volume":"33","author":"M Yu","year":"2013","unstructured":"Yu M, et al. TNF-\u03b1-secreting B cells contribute to myocardial fibrosis in dilated cardiomyopathy. J Clin Immunol. 2013;33(5):1002\u20138.","journal-title":"J Clin Immunol"},{"issue":"7","key":"1722_CR92","first-page":"8107","volume":"8","author":"Y Guo","year":"2015","unstructured":"Guo Y, et al. Increased circulating interleukin 10-secreting B cells in patients with dilated cardiomyopathy. Int J Clin Exp Pathol. 2015;8(7):8107\u201314.","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"1722_CR93","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/ehf2.13793","volume":"9","author":"U Salzer","year":"2022","unstructured":"Salzer U, et al. Susceptibility to infections and adaptive immunity in adults with heart failure. ESC Heart Fail. 2022;9(2):1195\u2013205.","journal-title":"ESC Heart Fail"},{"issue":"1","key":"1722_CR94","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000488405","volume":"46","author":"J Jiao","year":"2018","unstructured":"Jiao J, et al. Defective circulating regulatory B cells in patients with dilated cardiomyopathy. Cell Physiol Biochem. 2018;46(1):23\u201335.","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"1722_CR95","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jcin.2009.08.010","volume":"2","author":"TT Goodchild","year":"2009","unstructured":"Goodchild TT, et al. Bone marrow-derived B cells preserve ventricular function after acute myocardial infarction. JACC Cardiovasc Interv. 2009;2(10):1005\u201316.","journal-title":"JACC Cardiovasc Interv"},{"issue":"15","key":"1722_CR96","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/CIRCULATIONAHA.105.606509","volume":"114","author":"H Mahrholdt","year":"2006","unstructured":"Mahrholdt H, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation. 2006;114(15):1581\u201390.","journal-title":"Circulation"},{"key":"1722_CR97","doi-asserted-by":"crossref","unstructured":"Caforio ALP, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636\u201348.","DOI":"10.1093\/eurheartj\/eht210"},{"issue":"1","key":"1722_CR98","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2353\/ajpath.2007.060544","volume":"170","author":"Y Matsumoto","year":"2007","unstructured":"Matsumoto Y, Park IK, Kohyama K. B-cell epitope spreading is a critical step for the switch from C-protein-induced myocarditis to dilated cardiomyopathy. Am J Pathol. 2007;170(1):43\u201351.","journal-title":"Am J Pathol"},{"issue":"5","key":"1722_CR99","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2230.2001.00852.x","volume":"26","author":"AM Powell","year":"2001","unstructured":"Powell AM, Black MM. Epitope spreading: protection from pathogens, but propagation of autoimmunity? Clin Exp Dermatol. 2001;26(5):427\u201333.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"1722_CR100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0168-1702(99)00041-6","volume":"62","author":"R Kandolf","year":"1999","unstructured":"Kandolf R, et al. Mechanisms and consequences of enterovirus persistence in cardiac myocytes and cells of the immune system. Virus Res. 1999;62(2):149\u201358.","journal-title":"Virus Res"},{"key":"1722_CR101","doi-asserted-by":"crossref","unstructured":"Tsch\u00f6pe C, et al.\u00a0Targeting CD20+ B-lymphocytes in inflammatory dilated cardiomyopathy with rituximab improves clinical course: a case series. Eur Heart J Case Rep.\u00a02019;3(3).","DOI":"10.1093\/ehjcr\/ytz131"},{"key":"1722_CR102","doi-asserted-by":"crossref","unstructured":"Jahns R, et al. Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest. 2004;113(10):1419\u201329.","DOI":"10.1172\/JCI200420149"},{"issue":"1","key":"1722_CR103","volume":"5","author":"AM Cordero-Reyes","year":"2016","unstructured":"\u2022\u00a0Cordero-Reyes AM, et al. Full expression of cardiomyopathy is partly dependent on B\u2010cells: A\u00a0pathway that involves cytokine activation, immunoglobulin deposition, and activation of apoptosis. J Am Heart Assoc. 2016;5(1):e002484.\u00a0This study establishes a clear connection between B cells and myocardial hypertrophy\/fibrosis and thus points to a potential role of B cells in the pathogenesis of HFpEF.","journal-title":"J Am Heart Assoc"},{"key":"1722_CR104","doi-asserted-by":"crossref","first-page":"14680","DOI":"10.1038\/ncomms14680","volume":"8","author":"M Kallikourdis","year":"2017","unstructured":"Kallikourdis M, et al. T cell costimulation blockade blunts pressure overload-induced heart failure. Nat Commun. 2017;8:14680.","journal-title":"Nat Commun"},{"issue":"11","key":"1722_CR105","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1111\/jcmm.14619","volume":"23","author":"P van den Hoogen","year":"2019","unstructured":"van den Hoogen P, et al. Increased circulating IgG levels, myocardial immune cells and IgG deposits support a role for an immune response in pre- and end-stage heart failure. J Cell Mol Med. 2019;23(11):7505\u201316.","journal-title":"J Cell Mol Med"},{"key":"1722_CR106","doi-asserted-by":"crossref","unstructured":"Baniaamam M, et al. Clinical improvement of cardiac function in a patient with systemic lupus erythematosus and heart failure with preserved ejection fraction treated with belimumab. BMJ Case Rep.\u00a02021;14(1).","DOI":"10.1136\/bcr-2020-237549"},{"issue":"8","key":"1722_CR107","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41591-021-01452-0","volume":"27","author":"GA Lewis","year":"2021","unstructured":"\u2022\u2022\u00a0Lewis GA, et al. Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial. Nat Med. 2021;27(8):1477\u201382.\u00a0This phase II trial showed that the immunomodulatory drug pirfenidone has beneficial effects in patients with HFpEF. Since murine data connects mechanistically the cardioprotective effects of pirfenidone to its B cell modulating properties, this study points at a potential role of B cells in human HFpEF.","journal-title":"Nat Med"},{"key":"1722_CR108","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104694","volume":"155","author":"A Aimo","year":"2020","unstructured":"Aimo A, et al. Pirfenidone is a cardioprotective drug: mechanisms of action and preclinical evidence. Pharmacol Res. 2020;155:104694.","journal-title":"Pharmacol Res"},{"key":"1722_CR109","doi-asserted-by":"crossref","unstructured":"Sanchez-Trujillo L, et al. Phase II clinical trial testing the safety of a humanised monoclonal antibody anti-CD20 in patients with heart failure with reduced ejection fraction, ICFEr-RITU2: study protocol. BMJ Open. 9(3):e022826.","DOI":"10.1136\/bmjopen-2018-022826"},{"issue":"3","key":"1722_CR110","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/cvr\/cvab113","volume":"118","author":"TX Zhao","year":"2022","unstructured":"Zhao TX, et al. Rituximab in patients with acute ST-elevation myocardial infarction: an experimental medicine safety study. Cardiovasc Res. 2022;118(3):872\u201382.","journal-title":"Cardiovasc Res"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-022-01722-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-022-01722-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-022-01722-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T05:21:36Z","timestamp":1659158496000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-022-01722-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,11]]},"references-count":110,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1722"],"URL":"https:\/\/doi.org\/10.1007\/s11886-022-01722-4","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,11]]},"assertion":[{"value":"16 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Luigi Adamo is co-founder of i-Cordis, LLC, a start-up company focused on the development of immunomodulatory therapies for heart failure, with a special emphasis on B cells and pirfenidone derivatives. He reports a small reimbursement for 1-h consultation for Cello Health BioConsulting. He also has patents planned, issued, or pending for WO\/2019\/028062, WO2010121122 A3, WO2008021465 A8, and US20070249038 A1. The other authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}